People are increasingly being asked to pay for services they could once access as part of the NHS for free.
Academic rigor, journalistic flair
Articles on COVID vaccines UK
Displaying 1 - 20 of 27 articles
New research shows that breastfeeding rates peaked in 2020, a time of strict COVID restrictions.
With COVID boosters expected to cost £100 when they go on sale in UK pharmacies, there are concerns about whether this will put people off getting the jab.
In a new study, we evaluated the effects of the 2021 COVID vaccine mandate introduced for staff in elderly care homes in England. Here’s what we found.
Widespread vaccination of children would likely avert thousands of cases of long COVID in the UK.
A vaccine produced by Sanofi is being given as part of the 2023 spring booster campaign. An immunology expert explains how it works.
Targeting vaccine campaigns only at vulnerable groups in future will, paradoxically, leave them at greater risk.
Clinically vulnerable people tended not to respond as well after the first and second shots, but their immunity rises to greater levels with a booster.
Data suggests the bivalent boosters are working well against omicron.
We don’t have a lot of scientific evidence on how much additional protection a fourth dose would offer younger adults. But on balance, giving them the option could be worthwhile.
For one, washing your hands is unlikely to prevent COVID spread.
The mental wellbeing benefits associated with COVID vaccination were substantial among older and clinically vulnerable people, but negligible for younger adults.
An immunologist looks at the evidence.
The UK has become the first country to approve the shot, which targets omicron alongside the original strain of SARS-CoV-2.
A new study looked at the health records of more than 9 million people in England to assess whether body weight influenced the uptake and effectiveness of COVID vaccines.
‘Hybrid immunity’ is the term for immunity acquired from both prior infection and vaccination.
The proportion of children aged five to 11 in the UK who have been vaccinated against COVID remains quite low. Why?
Pfizer and Moderna have both recently reported results for their COVID-19 vaccines in the youngest children.
A study of more than 28,000 UK adults has found that vaccination after having COVID is linked to a decrease in long COVID symptoms.
Scientists are working on intranasal COVID vaccines. Not only are these vaccines delivered differently – but they also target a different part of our immune system.
Top contributors
-
Personal Chair of Immunopathology, The University of Edinburgh
-
Lecturer in Psychology, Swansea University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Cancer Virology, University of Leeds
-
Professor of Law, University College Cork
-
Senior Lecturer, Medical Microbiology, University of Westminster
-
Chair of Industrial Economics, Nottingham University Business School, University of Nottingham
-
Professor of Primary Care Health Sciences, University of Oxford
-
Professor of Economics and Behavioural Science, University of Leeds
-
Senior Lecturer in Immunology, Cardiff Metropolitan University
-
Professor of Medicine, University of East Anglia
-
Senior Researcher, Diet and Obesity, University of Oxford
-
Research Fellow in Virology, University of Leeds
-
Associate Head (Students), School of Biological Sciences, University of Portsmouth
-
Professor of Law, University of Liverpool
